MarketLens
Sign Up

What's Behind Natera CEO Steven Chapman's Recent Stock Sales

7 months ago
SHARE THIS ON:

What's Behind Natera CEO Steven Chapman's Recent Stock Sales

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000

Maze Therapeutics CMO Harold Bernstein sold 9,705 shares for ~$255,000 on September 4, 2026, equal to 100% of his directly held common stock before the filing.
Stock News•1 months ago

Astera Labs Chairman Manuel Alba Sells 183,000 Shares for $51.3 Million. How Big of a Red Flag Is This?

Astera Labs Chairman Manuel Alba sold ~183,000 shares at a weighted average price of $280.13 for ~$51.3 million, trimming 12% of his pre-filing stake and leaving ~1.4 million shares.
Stock News•2 months ago

Natera Shares Soar Over 20% To All-Time High, Bolstering Co-Founder's Billionaire Status

Natera shares rose over 20% to an all-time high, after a strong year-to-date gain of 40.6% from ~$228. The stock's 2025 low was $182.65 in late March, boosting co-founder's billionaire status.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Farkas Says Starlink Slowdown Helped the Russians

Stock News•1 hour ago

Amazon (AMZN) Suffers a Larger Drop Than the General Market: Key Insights

Stock News•1 hour ago

Here's Why Dell Technologies (DELL) Fell More Than Broader Market

Stock News•1 hour ago

Microsoft (MSFT) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Elon Musk's Tesla eyes transportation ‘domination' as Cybercab expansion heats up competition with Waymo